ukti cphi trade mission delegates to meet any of...
TRANSCRIPT
UNCLASSIFIED
UKTI CPhI Trade Mission Delegates
To meet any of these UK companies, please visit the Great Britain Pavillion, Stall Number- U2, Hall-2, Bombay Convention and Exhibition Centre, Goregaon
1.IMPECTRON LIMITED
Unit 411 Centennial Park,
Elstree,
Hertfordshire,
WD6 3TN
United Kingdom
Contact: Hilton Ellison, CEO
Email: [email protected] Website: www.impectron.com
Tel: +44 (0) 844 272 8888
About the Delegate: Hilton Ellison is a pharmacist by profession. He is the
founder and managing director for Impectron.
About the Company: Impectron ltd is a family business established in 1995 and
it is a manufacturer and importer/exporter of high quality health care products
including mobility and rehabilitation aids as well as pressure care products. The
company was founded in 1995 and distributes throughout the United
Kingdom. Impectron is actively looking for new export markets and
partners/distributors overseas.
UNCLASSIFIED
Impectron's Trade Mark "Dynamix" brand comprises an extensive range of
over 100 product lines of elasticated, orthopaedic supports.
The range consists of:
Arm Slings
Neck Collars
Ankle Compression supports
Knee elasticated supports
Wrist supports and stabilisers
Maternity Belts, Hernia and Scrotal supports
Full range of breathable Shoulder, Abdominal and Lumbar supports
Elbow supports and many others.
They also distribute a range of sheepskin products for comfort, pressure care
and pressure-sore prevention.
Products are manufactured from a variety of materials depending on their
applications and all meet the highest standards of quality, compliant with
stringent UK, EU and US regulations, which will give confidence to buyers
abroad. All our products are made from comfortable, breathable materials,
long lasting and durable.
Examples of the Dynamix Range of products as well as information and
literature will be available for examination. All enquiries will be warmly
welcomed.
They would like to;
To establish export business for our British company, in India and
countries of South Asia.
Build contacts with principals, buyers, agents, and distributors
To showcase the extensive range of products and to provide buyers the
opportunity of face to face discussions with us in order that we may
demonstrate the products and give buyers the opportunity of examining
the products
Our expectations are for good and long term business relationships and
friendships with new partners, distributors and customers.
UNCLASSIFIED
2.INTERTEK PHARMACEUTICAL SERVICES
Hexagon Tower,
Blackley,
Manchester,
M98GQ
United Kingdom
Contact: Ashleigh Wake, Biotechnology Project Manager Email: [email protected] Website: www.intertek.com/pharmaceutical/
Tel: +44 (0) 161 721 5247
About the Delegate: Ashleigh Wake is the Biotechnology programme Manager
for Intertek Pharmaceutical Services. Ashleigh graduated from Huddersfield
University with a BSC in Analytical Chemistry. With a background of mass
spectrometry and a career of almost two decades as an operational/ technical
team leader and study director for projects spanning the drug development
process (including metabolism, pharmacokinetic studies and API/ product
characterisation and stability studies), Ashleigh has specialised in the design
and delivery of regulatory (GXP) studies relating to the physiochemical and
biological activity of bio molecules. Ashleigh is responsible for the strategic
growth and technical direction of Intertek’s centre of excellence for biologics
characterisation in Manchester, UK. Intertek‘s strategy has been to establish a
one source solution for the protein analysis relating to the requirements of ICH
Q6B.
UNCLASSIFIED
About the Company: Intertek is a leading contract service organisation
providing comprehensive cGMP/GLP analysis, immunochemistry, sustainability
and supply chain management solutions for developers and manufacturers of
Pharmaceuticals, biopharmaceuticals, OINDP, transdermal and medical
devices. Our capability includes protein characterisation, extractables/
leachable, method development/ validation, impurity/ degradation, product
identification, release testing, ICH stability studies. Intertek‘s regulatory
consultants ensure comprehensive regulatory support for fast track
approaches to new product introduction and regulatory compliance.
With facilities located across Europe (UK, France, Switzerland) and USA,
Intertek responds precisely to support you need to accelerate your speed to
market.
UNCLASSIFIED
3.Sigma Pharmaceuticals plc
Unit 1-7 Colonial Way,
PO Box 233,
Watford,
Hertfordshire
WD24 4YR
United Kingdom
Contact: Bharat Shah, Managing Director Email: [email protected] Website: www.sigmaplc.co.uk
Tel: +44 (0) 1923331401
About the Delegate: Dr Bharat Shah is Sigma Pharmaceuticals plc MD with
special responsibilities in the operational side of the business. He started the
company in 1982 and now, with a team of five Directors, has overall
responsibility for driving the core businesses that incorporate Licensed
Generics, Parallel Imports, Branded Products, Surgical/Wound Care, OTC
Medicines, Mobility and Veterinary. The businesses are marketed under
several corporate sub-brands that account for over £200 million worth of
turnover. Sigma has a daily schedule of medical/drugs delivery to UK
pharmacies, doctors, hospitals and care homes with a staff of 400 and a fleet
of 50 vans. On average, Sigma delivers to some 3000 customers daily and some
8 millions packs of medicines monthly.
UNCLASSIFIED
Contact: Claire Ward, Export Consultant & CEO IPF Email: [email protected] Website: www.sigmaplc.co.uk
Tel: +44 (0) 1923331401
About the Delegate: Claire is the CEO of the Independent Pharmacy Federation, a representative and leadership body for independent pharmacists in the UK. She is also an export development consultant working with Sigma Pharmaceuticals plc. I hope to develop new business opportunities for Sigma and also to encourage the wider pharmaceutical industry to understand the nature of retail pharmacy and generic manufacturing in the UK. About the Company: Sigma Pharmaceuticals is a family owned business
established in 1982, employing over 400 people. It is the largest independent
chemist distributor within the UK. Sigma Pharmaceuticals services 3800
Pharmacy accounts, 600 dispensing practices, 1000 national hospitals. They
service multiple pharmacies like; Alliance Boots, Lloyds Pharmacy, Rowlands,
Sainsbury’s, Tesco, Co-op, Cohens, Superdrug & Day Lewis.
Sigma Pharmaceuticals is a major player in generics medicines in the UK. They
hold many pharmaceutical licenses and source products from many low cost
countries. They have their own team of SQP’s and have approved several
factories for MHRA approval in India and far East. Sigma Pharmaceuticals have
innovated and piloted Almus brand on behalf of Alliance Boots and have the
complete range stocked.
Sigma Pharmaceuticals is expecting to make contacts with Indian
pharmaceutical companies, for technology transfers that would be of interest
in the UK. These are generic products which could be standard commodity
generics, specialised generics or more complex generic formulations. We are
also seeking to make contacts with companies in India and overseas, with a
view to exporting UK pharmaceutical products to countries outside the EU. We
are very keen to export UK generics medicines, UK OTC medicines, UK
veterinary ‘companion pets’ medicines and mobility and disability equipment.
We are also offering on behalf of Apotex a novel orphan drug which Apotex
wishes to find a suitable marketing partner in India.
UNCLASSIFIED
About Almus Pharmaceuticals (Represented by Sigma Pharmaceuticals): Almus pharmaceuticals is a brand owned by Alliance Healthcare in the UK and Sigma Pharmaceuticals are one of the distributors of one the products in the UK. Alliance Healthcare is seeking to make contacts with India pharmaceutical companies that have licensed products in the UK, Europe and USA. Almus could also look to partner licence development in UK & Europe.
UNCLASSIFIED
4.Trinity Scientific (DDD Group)
94, Rickmansworth Road
Watford,
Hertfordshire
WD187JJ
United Kingdom
Contact: Shaheen Akhgar, Head of Trinity Scientific
Email: [email protected]
Website: http://www.dddgroup.co.uk/
Tel: +44 (0) 1923 229 251 Extn: 5748/ 07977989687
About the Delegate: An experienced commercial manager for a
pharmaceutical contract laboratory with a background in analytical testing and
method development.
About the Company: DDD Limited comprises of a group of companies which
between them offer a complete service to take a health and beauty product
from idea to a consumer’s shopping basket.
UNCLASSIFIED
Contact: Joanna Bristow, Commercial Manager Email: [email protected] Website: http://www.dddgroup.co.uk/ Tel: 01923 229251 ext 5741 M: 07977989666 About the delegate: An Experienced commercial manager for a pharmaceutical and toiletry manufacturer with a background in sales, marketing and product development. About the company: DDD Limited comprises a group of companies which between them offer a complete service to take a health and beauty product from idea to a consumer’s shopping basket.
UNCLASSIFIED
5.Johnson Matthey Chemicals India Pvt Ltd
Plot No 6A, MIDC, Industrial Estate, Taloja, Dist Raigad - 410208 Maharashtra, India
Contact: Mr Rajneesh Kumar, National Sales Manager Email: [email protected] Website: www.jmcct.com
Tel: +91 22 2740 1410
Contact: Mr Nitin Patil, Technical Sales Manager Email: [email protected] Website: www.jmcct.com
Tel: +91 22 2740 1410
About the Company: Johnson Matthey is a leading speciality chemicals
company underpinned by science, technology and our people. A leader in
UNCLASSIFIED
sustainable technologies, many of our products enhance the quality of life for
millions of people around the world.
Catalysis and Chiral Technologies is the only global catalytic technology partner
that can provide trusted expertise for heterogeneous, homogeneous, chiral
and biocatalytic technologies, for customers in the pharmaceutical, fine
chemical and agrochemical industries. We deliver high quality products and
excellent service to help our customers reduce their development and
manufacturing costs.
UNCLASSIFIED
6.Auden McKenzie:-
Name: Mr Janit Patel Position: Director, Business Development and Commercial Strategy Email: [email protected] Mobile: +44 7889534866 Name: Mr Parag Patel Position: Head of New Product Development Email: [email protected] Mobile: +44 7860505347 Name: Mr Ashish Kakabalia Position: Head, India Liaison Office Email: [email protected] Mobile: +91 9930471654
Companies Profile:-Is a privately owned, dynamic and fast growing company
focused on the development, licensing and marketing of niche generic
medicines and proprietary brands in the UK and globally.
Product Licence:-Auden McKenzie currently holds 175 Product Licenses. The
company has developed a unique model to sustain small but clinically
significant molecules to meet patient needs globally. Product Licences
Product Portfolio: - Product portfolio consists of a broad range of molecules in various dosage forms, for the treatment of a cross section of therapeutic areas. Product Portfolio Specialities:-The Company specialises in the development and registration of high value, technically demanding formulations and also pursues first to file opportunities. Specialities Capabilities: - Access to both in-house and external regulatory, development and manufacturing capabilities in Europe and Asia. Capabilities
UNCLASSIFIED
Future Focus:-Pharmaceutical products in various stages of development and registration. Future Focus
Summary for this visit.
To form new partnerships with CMOs and CROs in INDIA.
7.ESB Developments Limited:-
ESB Developments Limited Unit 7 Park Lane Business Centre Nottingham United Kingdom Tel +44 115 9771054 www.esbdevelopments.co.uk
Contact Name: - Mark Broughton
Contact Profile: - Analytical Chemist and one of the founding Scientists of “Vitashine” raw materials, true plant source of Vitamin D3, Cholecalciferol. Mark has worked in Pharmaceutical and Food Supplement Industry for over 28 years developing new formulations and supplying products to some of the biggest pharma ceutical and food Supplement companies in Europe.
Organisation’s profile:-
ESB Developments Limited: Is a research and development company
specializing in unique raw materials for use in Foods, Food Supplements and
Pharmaceuticals. We are promoting Vitashine the first and still only Vegan
Society approved plant derived source of Vitamin D3. Vitashine is available as
oil and powder, suitable for addition to a complete range of consumer
products including food fortification, food supplements and pharmaceuticals.
Vitamin D deficiency is a problem globally, Vitashine offers a nutritional
solution to this deficiency and is acceptable to all consumers no matter if meat
or non-meat eaters. ESB will also be showcasing its full range of consumer
products currently sold in Europe & North America which they are seeking to
distribute wider in Asia. All ESB’s products are from non-animal source, 100%
sustainable and packed with nutritional value for the consumer.
UNCLASSIFIED
8.UKIBC-
UK India Business Centre 7th Floor, Tower B, Infinity Towers, Gurgaon, Haryana E: [email protected] T: +91 124 4537 800
Organisation Profile:-
UK India Business Council is the premier business-led organisation promoting
bilateral trade and investment between the two countries. Our mission is to
facilitate an increase in trade between the UK and India through business to
business dialogue.
UKIBC plays an influential role in creating and sustaining an environment in
which free-trade and investment flourishes. Through the facilitation of
partnerships, and with an extensive network of influential corporate and
individual members, UKIBC provides the resource, knowledge and
infrastructure support vital for UK companies to make the most of emerging
opportunities in India.
Rohit Singh – Head of Market Entry & Research, India
Rohit Singh is a graduate in Mechanical Engineering with post-graduation in
Logistics & Supply Chain Management from XLRI, Jamshedpur. Having
worked with Maruti Suzuki and Hero Honda Motors, he brings in vast
manufacturing industry experience with a proven track record in vendor
development, global sourcing and supply chain management. Prior to
UNCLASSIFIED
joining UKIBC, he worked in India’s leading market entry consulting firm, Tecnova; where he
spearheaded many industrial, automotive and engineering projects from the global clients
on the India market research, sourcing, business feasibility analysis, India entry strategy
formulation and implementation. He has hands on experience on Indian regulatory
environment and corporate affairs and has been instrumental in setting up of factories,
establishing the business start-up and managing the business transition of many US and
European companies in India.
He can be contacted at [email protected] M: +91 (0) 882 681 9955
Atul Khurana – Sector Adviser, Healthcare & Life Sciences
Atul Khurana, is a Bachelor of Pharmaceutical Sciences, M.B.A. from University of
Pune and Diploma clinical research. Atul has diversified experience of working in
various segments of healthcare & Pharma sector like Dental Implants, Heart
valves Medical equipment’s & devices, Diagnostics, OTC, Generic API, Pharma
Packaging, Home Health, Medical disposables , Anti diabetics. Biotechnology
equipment’s etc. Atul’s core expertise lie in Market assessment, Market research, Competitive
landscaping, capturing trends and key success-factor analysis, business partner identification
and introductions, managing client expectations, scoping projects, providing insights to
requirements and managing conflict situations. He is also highly experienced in working with
facilitating collaboration across multiple work streams and consensus building with senior
Management and diverse teams.
He can be contacted at [email protected] M: +91 (0) 882 681 9966
9.Phynova
Phynova House 16 Blenheim Office Park Long Hanborough Oxfordshire 0X29 8LN UK Tel: 01993 880 700 Fax: 01993 886 687 Email: [email protected] Website: - http://www.phynova.com/
UNCLASSIFIED
Delegate profile:
Andrew Gallagher – Chief Operating Officer Andrew has been developing healthcare products (Rx, OTC and consumer healthcare) from plants for a number of years. He has broad operational experience across the development value chain, from product discovery to clinical development and commercialisation. He previously worked as biochemistry lecturer at the University of Natal (South Africa) and in business development for the clinical research organisation Kendle (acquired by INC Research). Andrew holds an MSc (Biology) from the University of Natal and an MBA (Finance) from the University of Leicester.
E: - [email protected]
Aatraye Almast – R&D Manager
Aatraye got involved in the study of medicinal plants during her MSc (Biotechnology) at Indian Institute of Technology, Roorkee. Her interest in commercialising plant based compounds led her to pursue a management course from the University of Cambridge where she received a 360 degree view of the global, regulatory, commercial and legal environment, of the
UNCLASSIFIED
pharmaceutical and biotechnology industry. Through Phynova, she envisions sharing the fruits of Ayurveda and other plant based medicinal systems with the world.
Company profile
Phynova is an innovative life science company based in Oxford with a
subsidiary research company located in Beijing, China. Phynova has developed
natural plant-derived actives for use in multi-billion markets in
pharmaceuticals and fast-moving consumer goods (FMCG), focused on
consumer healthcare. Phynova’s product portfolio includes functional
ingredients for metabolic syndrome, including moderating blood glucose
levels, an OTC drug candidate for the relief of arthritis and a pharmaceutical
drug candidate for post-operative ileus.
Phynova’s core strength is its East-West bridge, built on its geographical
presence and cross-cultural team. Phynova’s advantage also lies in its ability to
leverage its Eastern and Western phytochemical expertise, patent estate,
understanding of global regulatory pathways and market pathways to cost
effectively develop novel drugs, medical foods and functional ingredients for
global markets. Additionally, Phynova has an experienced international
management team with a strong track record.
Phynova has several ready-for-market products and is seeking strategic
corporate partners to commercialise these products in multiple global markets.
Mission’s objectives
The recently introduced Drug Price Control Order (DPCO) that caps the price of
essential medicines in India has considerably affected margins and turnover of
small-mid sized pharmaceutical companies. As a mitigation strategy, many
such companies are shifting their portfolio towards nutraceuticals and plant
based (Ayurvedic) segments due to fewer price controls. Furthermore, some of
the leading OTC medicines in India are Ayurvedic thereby making the segment
extremely promising. Considering these, Phynova would like to collaborate
UNCLASSIFIED
with domestic pharmaceutical, consumer healthcare, and food companies
following its line of similarly established alliances in other parts of the world.
Phynova’s three main objectives for the mission are:
Identification of collaborative partners for commercialisation of our blood glucose regulating functional ingredient IminoNorm™: India is the largest sugar manufacturer globally and has the second largest diabetic population in the world. Whilst sugar substitutes exist, many consumers still prefer sugar’s organoleptic profile and have proved reluctant to reduce consumption to improve their health. This presents an attractive opportunity for products that can mitigate its harmful side-effects rather than replacing it. IminoNorm is a functional ingredient that can be incorporated into foods/drinks to allow people to still enjoy the taste of sugar but with reduced harmful side-effects – it is not a sugar replacement.
Identification of potential manufacturing partners for the large scale
production of IminoNorm and Phynova’s other proprietary products.
Identification of partners for registration of Ayurvedic plants under
THMP guidelines: Following conditional approval of its first Traditional
Herbal Medicinal product (THMP) for joint pain, Phynova is working on
the registration of several other medicinal plants under these guidelines
established by the EU directive and would like to collaborate with Indian
companies.
10.Arc Pharma
ARC Pharma UK Limited
3 Admiral House Cardinal Way Harrow Wealdstone Middlesex United Kingdom HA3 5TE Tel: +44(0) 020 8427 2921
UNCLASSIFIED
Email: [email protected]
Our Contact Details:
Mr. Janak Patel – Finance Director
Email: [email protected] – Mobile: +44 (0) 7939032342
Mr. Ayan Patel – Director
Email: [email protected] – Mobile: +44 (0) 7515442095
Mr. Ketan Pipaliya – Head of Quality and Compliance
Email: [email protected] – Mobile: +44 (0) 7448366070
Company Profile:
We are proud to introduce ARC Pharma (UK) Ltd a GMP Certified Contract
Laboratory, a new name in Pharmaceutical and Healthcare analytics, but old
hands at providing our partners with an outstanding, quality driven service.
ARC offers analytical laboratory testing, from advanced R&D research projects
to routine quality testing. We provide these services through experienced and
UNCLASSIFIED
expert chemists, analysts, technicians and laboratory management. Ongoing
investment in the best people and equipment helps us keep ahead of the
game, maintaining the highest levels of reliability and service. ARC also
provides materials testing services for a broad range of partners in diverse
markets and industries. Using analytical laboratory techniques, laboratory
instrumentation and testing methods, we provide our partners with critical
analysis information. Whether its research, quality control or just plain trouble-
shooting, our aim is to give you the crucial support you need to help your
business meet its research, development, patient safety and quality goals and
also doing analytic testing for the pharmaceutical companies.
Our services:
QC Batch Release Testing
Test Method Development
Test Method Validation
Pharmacopoeial Testing
Dissolution Profiling
Technical Projects
cGMP Laboratory Facilities
Consultancy
GMP Audits including API, Formulation ( Sterile and Non Sterile) and Distribution
Our Objectives:
We would like to build a long-term trusting relationship which provides each
partner with a bespoke service. It may be our ‘get it right first time’ attitude,
UNCLASSIFIED
encapsulating the efficient way we go about our business, fully understanding
the brief, thoroughly testing and checking results, meeting promised deadlines
and communicating clearly to help our partners achieve their goals.